TickerTalks
Browse all tickers →
TickerTalks›$ZNZNF
ZNZNZNF

Zinzino AB (publ)

$ZNZNF·$521M·Household & Personal Products·Consumer Defensive
$13.47-4.6%YTD-18.6%1Y-47.5%
Mentions · last 7 days
0
Price updated 14d ago·X counts updated 16d ago
ZNZNZNF
$ZNZNFZinzino AB (publ)
$13.47-4.64%0 posts
AI analysisFundamentalsVoices on X
Loading…

AI verdict & sentimentAI analysisGenerated by AI from underlying data

Today's AI verdict on what's driving $ZNZNF, plus how loud the X conversation is and which way it's leaning.

AI analysis

TickerTalks’ read on the fundamentals and what’s driving the move.

Proven numbersWinding up for a moveAI verdict · as of 2026-08-13

Trading in a tight range and building pressure — a move looks likely soon, but the direction isn't clear yet.

Zinzino — Swedish direct-sales nutraceuticals — TTM -47% at 15% of 52w range, but Q1 rev +27% YoY and Aug 25 next print as the coil breaker.

Zinzino AB is a Gothenburg, Sweden-based direct-to-consumer/network-marketing nutraceutical + coffee company — nutritional supplements (immunity, weight management, skin), plus espresso machines/coffee/tea and accessories — with a global 30+ country distributor network across Nordics, EU, US, Asia-Pacific. Market cap $521M.

  • Q1 FY26 revenue SEK 922M, +27.4% YoY with 37% gross and 14% op margin — the international-expansion cadence is intact, and the May 22 EPS beat +9.8% follows the Feb 25 beat +27.5%, so operating results have been beating.
  • The tape has punished despite operating beats: TTM -47%, YTD -19%, at 15% of 52-week range and -3% vs. 50DMA — network-marketing regulatory scrutiny (EU/US MLM concerns) and consumer-defensive multiple compression have been the overhang.
  • Trades 13.6x TTM P/E, 9.7x EV/EBITDA, 52% ROE, and 12% FCF yield with essentially no debt — cheap on cash-conversion metrics for a name compounding revenue at 20%+, but the multiple only re-rates if regulatory overhang lifts + operating cadence continues.

What extends the coil upward: Aug 25 Q2 confirming continued 20%+ revenue growth and clean cash EPS. What breaks it down: another quarter of tape decoupling from operating results, or an EU/US regulatory action on direct-selling model compliance.

What to watch: Aug 25 Q2 earnings — YoY revenue growth continuity across geographies, distributor count / active-customer disclosure, gross margin trajectory. Also monitor Nu Skin, Herbalife, Usana for direct-sales peer reads and any EU/US MLM regulatory news.

On the calendar: 2026-08-25 — Q2 earnings

Read the AI verdict + X sentiment for $ZNZNF

  • One-line verdict on what's driving the move — fundamentals, momentum, both, or an event
  • Next dated catalyst when there is one (earnings, deal closing, activist clock)
  • X crowd read with bullish/bearish call + post volume
Free, forever. No credit card.

What it does

Plain-English summary of the business — what they sell and how they make money.

Sells omega-3 supplements, probiotics, and coffee via direct sales in Nordic and European markets; personalized health brand with test-based nutrition.

Industry overviewAI analysisGenerated by AI from underlying data

Where Household & Personal Products sits in its cycle right now — and what that implies for $ZNZNF.

Household & Personal Products · Consumer Defensive

No material change from last week — inflation-weary consumers sustain spend on trusted daily-use brands (Colgate, Pepsi) while trading down in discretionary categories.

What this means for $ZNZNF

Neutral — Sells omega-3 supplements, probiotics, and coffee via direct sales in Nordic and European markets; personalized health brand with test-based nutrition; limited read-through from household & personal products macro dynamics to this specific revenue mix.

Industry benchmark

13-name peer basket
-1.7%YTD
-14.2%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
13.6How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
24.3%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
12.1%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
12.1%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
1.5Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
51.6%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
28.2%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
0.1Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q1 2026May 22, 2026$0.29$0.27+9.8%
Q4 2025Feb 25, 2026$0.35$0.28+27.5%
Q3 2025Nov 19, 2025$0.03$0.18-85.4%
Q2 2025Aug 29, 2025$0.02$0.16-89.6%
Next earningsTue, Aug 25·consensus EPS $0.22

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q1 FY26$922.1M+27.4%37.0%14.2%$2.79$123.6M
Q4 FY25$983.1M+37.9%11.8%11.8%$3.41$270.8M
Q3 FY25$78.7M-85.2%8.1%8.1%$0.26$14.3M
Q2 FY25$752.6M+48.8%4.2%4.2%$0.17$108.0M

Forward consensus

4-year forecast · up to 1 analysts
FYRevenueRangeEPSRangeAnalysts
FY26$4.0B$4.0B – $4.0B$10.17$10.17 – $10.171
FY27$4.5B$4.5B – $4.5B$11.25$11.25 – $11.251
FY28$4.8B$4.8B – $4.8B$12.19$12.19 – $12.191
FY29$4.8B$4.8B – $4.8B$13.03$13.03 – $13.031

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.0.1×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.12%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.-6.1%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.-12.0%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatLow float · 22.1M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today0.0% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β1.075-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.ListedOTCListed on an over-the-counter market (PNK / OTCQB / OTCQX), not a major exchange. Lower disclosure requirements and thinner liquidity.

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

ZINZINO AB (PUBL.): YEAR-END REPORT 2025prnewswire.com·185d ago

More in Household & Personal Products

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$EL$CL$ELF$PG$COTY$KMB$KVUE$CLX
Voices on X · last 7 days

No standout posts about $ZNZNF on X in the last 7 days.

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport